The cryptocurrency market is experiencing significant declines, with bitcoin's discount from its historical highs reaching nearly 15%. The altcoins are losing more heavily than the main cryptocurrency. Ethereum falls by more than 7%, while Solana is similarly discounted by more than 10%, as is Dogecoin. Following yesterday's 15% discount to Microstrategy (MSTR.US) shares, the company's shares are trading down another 10% today ahead of the US market open.
- The strengthening dollar has put pressure on cryptocurrencies giving investors an excuse to realise record profits
- The average buy price of investors in ETFs is around USD 50 000 which still implies an average gain of 25%
- The average buy price of short-term investors is hovering around USD 46,000 which, despite recent declines, implies an average gain of around 35%
- ETFs are seeing limited inflows, with outflows from Grayscale (GBTC) yesterday proving to be the highest on record (US$642m), pulling the overall net balance into negative territory
Bitcoin (D1)
In addition to the onchain levels (USD 50,000, USD 46,000), very far from the current price, it is worth noting the 23.6 and 38.2 Fibonacci retracement (around USD 60,000 and USD 50,000). The SMA50, which the market, after entering the most dynamic phase of the bull market in October 2020, did not test until May 2021, may also prove to be an important momentum support. The average has not been tested since around 20 January 2023.
Daliy Summary: Iran Seeks Truce as Markets Brace for Wednesday
Crypto News โก Bitcoin under Pressure: Will it drop again?
Morning Wrap: Ceasefire Fuels Wall Street Gains, but Political Uncertainty Remains
Bitcoin surges almost 4% to the highest level since the beginning of February 2026
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
